March 19, 2025 - 00:26

In a groundbreaking advancement, researchers have developed a novel technology that enables the simultaneous testing of approximately 25 different antibodies in a single laboratory mouse. Traditionally, the evaluation of new active ingredients like antibodies has been conducted individually, often requiring multiple animals for comprehensive analysis. This innovative approach not only streamlines the testing process but also significantly reduces the number of animals needed for research.
The new method leverages advanced techniques to assess the efficacy and interactions of various antibodies concurrently, providing a more efficient and ethical framework for preclinical studies. This development could accelerate the pace of biomedical research, particularly in fields such as immunology and therapeutic development, where understanding the complex dynamics of antibody interactions is crucial.
By enhancing the ability to conduct thorough testing within a single subject, this technology holds promise for improving the reliability of results and fostering more rapid advancements in medical science. Researchers are optimistic that this approach will lead to more effective treatments and better outcomes for patients in the future.
May 17, 2026 - 03:46
What do China’s plans for new AI law mean for future of technology?The State Council has outlined its plans to `accelerate comprehensive legislation for the sound development` of artificial intelligence. This move signals Beijing`s intent to establish a formal...
May 16, 2026 - 08:14
Click Technology to Invest US$17 Million in CoahuilaA new wave of industrial investment is hitting northern Mexico. Click Technology, a firm specializing in precision components, has committed $17 million to establish a manufacturing facility in the...
May 15, 2026 - 20:08
Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics Shares Plummet, What You Need To KnowA broad selloff hit several semiconductor and chip-equipment stocks during the afternoon trading session on Monday. The decline followed the conclusion of the U.S.-China summit, which ended without...
May 15, 2026 - 06:47
OpenAI Trial Heads to Jury After Closing Arguments in Musk vs. Altman CaseSAN FRANCISCO -- The high-stakes legal fight between Elon Musk and OpenAI moved one step closer to a verdict on Thursday, as attorneys for both sides delivered their closing arguments in federal...